BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 3917847)

  • 1. The involvement of polyamine uptake and synthesis pathways in the proliferation of neonatal astrocytes.
    Malpica-Nieves CJ; Rivera-Aponte DE; Tejeda-Bayron FA; Mayor AM; Phanstiel O; Veh RW; Eaton MJ; Skatchkov SN
    Amino Acids; 2020 Aug; 52(8):1169-1180. PubMed ID: 32816168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of combination treatment with alpha-difluoromethylornithine and Corynebacterium parvum on B16 melanoma growth and tumoricidal effector cell generation in vivo.
    Bowlin TL; Rosenberger AL; Sunkara PS
    Cancer Immunol Immunother; 1985; 20(3):214-8. PubMed ID: 3933819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of putrescine uptake in hamster amelanocytic melanoma AMEL-3 cells.
    García-Fernández AJ; Rodríguez RA; Pérez-Pertejo Y; Balaña-Fouce R
    Mol Cells; 2005 Aug; 20(1):127-35. PubMed ID: 16258251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity.
    Kim DJ; Roh E; Lee MH; Oi N; Lim DY; Kim MO; Cho YY; Pugliese A; Shim JH; Chen H; Cho EJ; Kim JE; Kang SC; Paul S; Kang HE; Jung JW; Lee SY; Kim SH; Reddy K; Yeom YI; Bode AM; Dong Z
    Cancer Res; 2016 Mar; 76(5):1146-1157. PubMed ID: 26676750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of putrescine uptake by polypyridinium quaternary salts in B16 melanoma cells treated with difluoromethylornithine.
    Minchin RF; Martin RL; Summers LA; Ilett KF
    Biochem J; 1989 Sep; 262(2):391-5. PubMed ID: 2508626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-adenosylmethionine decarboxylase as target of chemotherapy.
    Jänne J; Alhonen-Hongisto L; Nikula P; Elo H
    Adv Enzyme Regul; 1985; 24():125-39. PubMed ID: 3939095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyamines: fundamental characters in chemistry and biology.
    Agostinelli E; Marques MP; Calheiros R; Gil FP; Tempera G; Viceconte N; Battaglia V; Grancara S; Toninello A
    Amino Acids; 2010 Feb; 38(2):393-403. PubMed ID: 20013011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of alpha-difluoromethylornithine on the in vivo uptake of 14C-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumor.
    Heston WD; Kadmon D; Covey DF; Fair WR
    Cancer Res; 1984 Mar; 44(3):1034-40. PubMed ID: 6420052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and ultrastructural characterization of human cell variants resistant to the antiproliferative effects of methylglyoxal bis(guanylhydrazone).
    Kramer DL; Zychlinski L; Wiseman A; Porter CW
    Cancer Res; 1983 Dec; 43(12 Pt 1):5943-50. PubMed ID: 6416670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice.
    Herr HW; Kleinert EL; Conti PS; Burchenal JH; Whitmore WF
    Cancer Res; 1984 Oct; 44(10):4382-5. PubMed ID: 6432312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time dependence of the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity caused by alpha-difluoromethylornithine-induced polyamine depletion in 9L rat brain tumor cells.
    Alhonen-Hongisto L; Deen DF; Marton LJ
    Cancer Res; 1984 May; 44(5):1819-22. PubMed ID: 6424930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the tissue disposition of methylglyoxal bis(guanylhydrazone) in mice by polyamine depletion and by polyamine administration.
    Kallio A; Seppänen P; Alhonen-Hongisto L; Jänne J
    Cancer Res; 1983 Jan; 43(1):324-7. PubMed ID: 6401167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of uptake and antiproliferative effect of methylglyoxal bis(guanylhydrazone) by treatment with alpha-difluoromethylornithine in rodent cell lines with different sensitivities to methylglyoxal bis(guanylhydrazone).
    Alhonen-Hongisto L; Levin VA; Marton LJ
    Cancer Res; 1985 Feb; 45(2):509-14. PubMed ID: 3917847
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.